A Multicenter, Randomized, Double-Blind Study of Erlotinib in Combination with Ramucirumab or Placebo in Previously Untreated Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer (I4T-MC-JVCY)
Supported projects > Other Supported Projects · 2017
Authors: Tuncay GÖKSEL
2017-2021, Other Supported Projects, R & D Project, Continues